Facilitating Skin-to-Skin Contact In the Postnatal Period
A Skin-to-Skin Contact (SSC) Facilitating Device Used Within a Mother-Infant Dyad: Exploring Its Acceptability, Usage and Effect on Health Outcomes in the Postnatal Period.
調査の概要
詳細な説明
Skin-to-skin contact is used as part of a package of Kangaroo Mother Care across the world. This has been demonstrated to reduce neonatal morbidity, mortality, and inpatient stays for low birth weight and preterm infants (Charpak and Ruiz 2016).
This study examines the effect a facilitating garment, the Snuby® has on neonatal health outcomes associated with skin-to-skin contact, such as neonatal thermoregulation, breastfeeding status, and self-reported mother-infant bonding. It uses a mixed methods approach to address quantitative and qualitative outcomes including participant's perspectives, and measurable health markers.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
West Midlands
-
Birmingham、West Midlands、イギリス、B15 3TN
- Birmingham City University
-
Birmingham、West Midlands、イギリス、B15 3TN
- Sandwell and West Birmingham NHS Trust
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Maternal participants
Inclusion Criteria:
Women, non-binary and transgender participants. Aged 16+ years old. Vaginal birth, including ventouse, forceps and spontaneous vaginal birth. 28+ weeks pregnant. Body Mass Index of 18 to 30 inclusive. Births between 37 and 42 completed weeks of pregnancy. Women without any morbidities that will significantly impair their ability to independently parent their baby.
Women planning to give birth on the labour ward, co-located birth centre, standalone birth centre or at home.
Exclusion Criteria:
Caesarean section births. High dependency Unit patients. Illiterate in English. Multiple pregnancies e.g. twins. Registered child protection concerns. Substance misusing women. Body Mass Index of less than 18 at booking appointment. Body Mass Index of more than 30 at booking appointment. Aged under 16 years old.
Neonatal participants
Inclusion criteria:
Born 37 to 42 completed weeks gestation. Birth weight between 2500g and 4000g . Weight at six weeks of age less than 6000g. Neonates requiring blood glucose prefeed monitoring. From birth to six weeks of age.
Exclusion criteria:
Preterm neonates (less than 37 weeks gestation). Requirement for special or intensive neonatal care. Receiving phototherapy. Receiving intravenous antibiotics. Falling growth velocity of more than 2 centiles. Aged over 6 weeks old.
Midwifery staff participants
Inclusion Criteria:
Working at the National Health Service Trust hosting the research. Working through the Hospital Bank. Registered midwife through the Nursing and Midwifery Council. Working on band 5, 6 or 7. Working within the hospital setting.
Exclusion Criteria:
Midwifery staff working in the community without rotating to the hospital wards.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：他の
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Snuby® users
This group receives the Snuby® skin-to-skin facilitating garment to use in the first six weeks following birth with their baby.
The use of the Snuby® garment is participant led, and used for as long and as often as they wish in the six week period.
|
Fabric garment designed to accommodate term neonates having skin-to-skin contact.
他の名前：
|
|
介入なし：Conventional Care
This group does not receive any intervention, and collects data on the research outcomes when having conventionally facilitated skin-to-skin contact, using a towel, blanket, or clothing as preferred.
Skin-to-skin contact frequency and duration is dictated by the participant.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Abnormal neonatal temperature
時間枠：Following 30 minutes of skin-to-skin contact, in both Intervention and Control groups.
|
Axillary temperature taken by the mother with Eco Temp Basic thermometer.
Abnormal: less than 36.5°C or more than 37.5°C.
|
Following 30 minutes of skin-to-skin contact, in both Intervention and Control groups.
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Breastfeeding Status
時間枠：Assessed at 3 days post birth, then weekly from day of birth until six weeks postnatal.
|
Exclusive breastfeeding, mixed breast and formula feeding, exclusive formula feeding, addition of expressed breastmilk.
Includes a comparison to self reported antenatal infant feeding intentions.
|
Assessed at 3 days post birth, then weekly from day of birth until six weeks postnatal.
|
|
Mother Infant bonding
時間枠：Six weeks post birth
|
Maternal participants will self report on their perspectives of skin-to-skin contact, and its role in the relationship bonding process between themselves and their babies.
|
Six weeks post birth
|
|
Neonatal Weight Velocity
時間枠：At a minimum of 3 intervals, including at birth, ten days, and at six weeks post birth.
|
Neonatal weight in grams to ensure suitable for Snuby® garment.
|
At a minimum of 3 intervals, including at birth, ten days, and at six weeks post birth.
|
|
Maternal participant's perspective
時間枠：Weekly until 6 weeks post birth
|
Maternal participants will self-report their views on the garment's ease of use and perceived value.
This will be compared to the control group reporting on the same outcomes with conventionally facilitated skin-to-skin contact.
|
Weekly until 6 weeks post birth
|
|
Midwifery participant's perspective
時間枠：12 months post birth of the first participating mother-infant dyad.
|
Qualitative data collection from midwifery participants, including their perspectives on skin-to-skin contact in the hospital setting, and the perceived value of the Snuby® garment.
|
12 months post birth of the first participating mother-infant dyad.
|
協力者と研究者
捜査官
- 主任研究者：Helen McIntyre, DHSci、University of Leicester
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。